How to use: Spiriva Handihaler®

Spiriva Handihaler® consists of the anticholinergic drug tiotropiumbromide. This medicin is used in the treatment of chronic obstructive pulmonary diseases, most often abbreviated as COPD.

Pharmacology: tiotropiumbromide is a long-acting anticholinergic drug. It blocks the muscarin receptor. This way, the neurotransmitter acetylcholine will not be able to bind on this receptor. The result is a relaxation of the bronchialic muscle tissue.

Always use this medication as your doctor/pharmacist advises you. The most commonly used therapy is the inhalation of one capsule a day, on the same hour each day.

How to use the Handihaler:
Step 1: It may sound logical, but open the cap and the mouth piece.

Step 2:
Gently take a Spiriva capsule. Place it in the open space. Close it off with the mouth piece until you hear a soft click. Press the green button FULLY on the side only once. By pressing this button, the capsule will be "pierced", creating small openings in the capsule, ready to inhale.

Step 3:
- Fully breath out as much as possible. Note: away from the Handihaler! We do not want the Handihaler to be humidified by the breath.
- Place yourself in a straight position, tilt your head a little bit backwards (this will open up the lungs, and this will prevent the drug to be stuck in the throat.
- Place your mouth on the mouth piece: place it between the teeths and enclose it with your lips.
- Breath in as hard as you can! Not through the nose however, watch out with that. While breathing in, you will hear a small zooming sound. This is the capsule spinning, making it possible to extract the drug out.
- Remove the Handihaler from the mouth. Try to keep in your breath for 5-10 seconds. Then, breath out slowly.

Repeat step 3 a second time: this will make sure all medicin is inhaled.

Step 4:
- Close off the Handihaler with the protection cap.
- Rinse your mouth with water! If a small fraction of tiotropium is left in the mouth, this could give a dry mouth, with possible complications. Always make sure to rinse your mouth with water after EVERY application.

Comments

Erythropoietin: definition, structure, synthesis in vivo

Definition: EPO: = erythropoietin A glycoprotein hormon-like structure, a sialoglycoprotein, which is an important factor in the survival, growth and proliferation of erythroid precursor cells (EPC) and it improves the de novo creation, differentation and growth of red blood cells (RBC). Thus, EPO controls the erythropoiesis = production of RBC. EPC: these are cells that are located in the bone marrow, will eventually form the RBC. RBC: cells responsible for the transport and distribution of oxygen throughout the body. Structure: Built out of 165 aminoacids (AA). They are all connected and form 1 polypeptide chain. Although, within the chain, there are 2 disulfide bonds. Respectively on positions: Cys7-161 and Cys29-33 Cys = cystein and the numbers indicate the positions these AA are located. Cystein structure. Available sulfide group for bonding There are also 4 positions where there is a possibility for glycosylation Namel...

The proteasome [1]: a crucial structure of protein degradation

The proteasome Proteins are constantly being synthesized and at the same time being degraded in each cell of our body. One of the most known mechanisms of proteolysis (= protein degradation) is the degradation done by lysosomes. However, an other important mechanism is degradation by the ubiquitin proteasome system (UPS). First of all, it is needed to understand that a cell maintains its protein concentration by a constant turn-over of proteins: when there is a lot of synthesis of a certain protein, this certain protein will also be degraded by a higher level, and vice versa. A protein that has to be degraded will be marked by a polyubiquitin chain which consists of 4 or more ubiquitinmolecules. This protein will be transported to a 26S proteasome. This structure in the cell is built by a 19S part and a 20S part. The 19S part mainly serves as a recognition and binding structure for the polyubiquitinated protein, and the 20S part will destroy the protein. Once attached to the...

Alkynes: addition of H2 gas and Lindlar catalyst

Alkynes: addition of Hydrogen gas (H2) Performing a catalytic reduction on an alkyn will result in giving an alkane. The alkene intermediate will be formed in the process, but will immediately react into an alkane. The end result is just the formed alkane, without stacking of the alkene intermediate. The Lindlar catalyst In theory this is a "poisoned or defected" catalyst. If you use a normal catalyst you will get the above effect with your alkyne. The Lindlar catalyst contains Palladium combined with Calcium-carbonate and treated with Lead. Palladium is the actual catalyst, the calcium carbonate is the carrier of the substance and the lead is the poisonous compound. Using the Lindlar catalyst instead of another catalyst together with Hydrogen gas, will lead into forming the cis-alkene intermediate instead of the forming of the corresponding alkane.

Pharmacist Blog about what I encounter and find useful/interesting

Search This Blog